SCHEMBL17544944

SCHEMBL17544944

Cc1c(C(=O)O)cc(CNCc2nnc(C)n2CCCC(C)C)nc1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17544930 0.83 GRIN2D (0.32) —
SCHEMBL17683848 0.81 GRIN2D (0.32) —
SCHEMBL17544969 0.74 GRIN2D (0.32) —
SCHEMBL17544743 0.71 CNR2 (0.32) —
SCHEMBL17545158 0.69 EHMT2 (0.40) —
SCHEMBL13737823 0.68 KDM4E (0.38) —
SCHEMBL17544666 0.67 EHMT2 (0.44) —
SCHEMBL17544842 0.64 CNR2 (0.33) —
SCHEMBL17544594 0.64 AGTR1 (0.33) —
SCHEMBL17544819 0.61 PDE6D (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9802941-B2 Compounds and methods for inhibiting histone demethylases GILEAD SCIENCES, INC. (US) 2017-10-31 — — US disclosed
EP-3186238-A1 COMPOUNDS AND METHODS FOR INHIBITING HISTONE DEMETHYLASES GILEAD SCIENCES, INC. (US) 2017-07-05 — — EP disclosed
US-20160102096-A1 COMPOUNDS AND METHODS FOR INHIBITING HISTONE DEMETHYLASES EPITHERAPEUTICS APS 2016-04-14 — — US disclosed
WO-2016033169-A1 COMPOUNDS AND METHODS FOR INHIBITING HISTONE DEMETHYLASES EPITHERAPEUTICS APS (US) 2016-03-03 — — WO disclosed
Send feedback